Blood bank red cells reagent- base plus 4
Ended Awarded Last action
- Contract number
- VA26316J0253
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $100,583
Award facts
- Contract value 51% obligated
-
- $101,654.55 Current, with exercised options
- $198,803.83 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- St Cloud, MN 56303, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$571 | |
| Funding Only Action | $20,812 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | -$175 | |
| Funding Only Action | $20,812 | |
| Exercise an Option | $0 | |
| Funding Only Action | $20,812 | |
| Exercise an Option | $0 | |
| Funding Only Action | $21,884 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | -$1,962 | |
| Original award | $18,970 |
Show all 12
About this award
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and other medical supplies. The contract, valued at $198,803.83, is for the delivery of "BLOOD BANK RED CELLS REAGENT- BASE PLUS 4" and has been set aside for total small business participation.
Alba Bioscience holds two significant Blanket Purchase Agreements (BPAs) with the VA under the General Services Administration (GSA) Schedule 65-VII for in vitro diagnostics, reagents, and tests. The first BPA, awarded to Veterans Integrated Service Network 10, has a ceiling value of $109,420.35 and runs through September 30, 2029, focusing on red blood cell reagents. The second BPA, awarded to Veterans Integrated Service Network 1, has a potential value of $30,000 and extends through September 2028, targeting blood bank reagents. These BPAs allow VA medical facilities to efficiently procure critical blood banking supplies through streamlined ordering processes, demonstrating Alba Bioscience's established position as a trusted supplier of essential medical products to the federal healthcare system.
Quick answers
Who was awarded contract VA26316J0253?
VA26316J0253 was awarded to Alba Bioscience, Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on January 8, 2016.
How much is contract VA26316J0253 worth?
The government has obligated $100,583 on VA26316J0253. Its current value, with exercised options, is $101,655. Its potential value, with all options, is $198,804.
Is contract VA26316J0253 an order under another contract?
Yes. VA26316J0253 is a delivery order under V797P2050D, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract VA26316J0253 competed?
The extent of competition for VA26316J0253 was full and open competition. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award